A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

Weight-loss drugs cannot be a short-term solution and GPs will need to engage with obesity management as the medicines are ...

Mumbai-based Supriya Lifescience is betting on a steady growth trajectory over the next few years, with Managing Director Saloni Wagh guiding for over 20% revenue growth annually. “That’s the guidance ...

"Social media will turn everyone into brain-dead zombies with a medieval-level understanding of the real world." ...

An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...

In an effort to promote the use of genuine products, Novo Nordisk is offering a one-time first-month offer for Wegovy at $199 ...

FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight -- without causing nausea.

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...